Skip to content

Plasma TREM2 - A Novel Non-Invasive NASH Biomarker

A plasma protein that can identify NASH patients from a single blood sample with high confidence

Published: 6th October 2021
Plasma TREM2 - A Novel Non-Invasive NASH Biomarker
PIC4U, stock.adobe.com
Patents
  • Patent application covering use of sTREM2 as clinical biomarker of NASH filed in May 2021
  • Additional matter of substance patent planned based on sequence of antibody developed for in house assay
  • The already filed patent dominates the use of sTREM2 as NASH biomarker, preventing others from developing own assay for clinical use
IP Status
  • Patent application submitted
Seeking
  • Development partner